M.V. Williams

Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report.

M.H. Cullen, Sally Stenning, M C Parkinson et al. · Journal of Clinical Oncology · 1996 · 319 citations

Medicine, Oncology, Pathology +16

Breast Cancer Risk After Supradiaphragmatic Radiotherapy for Hodgkin's Lymphoma in England and Wales: A National Cohort Study

Anthony J. Swerdlow, Rosie Cooke, Andrew Bates et al. · Journal of Clinical Oncology · 2012 · 167 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

Sophie D. Fosså, Sally Stenning, A. Gerl et al. · British Journal of Cancer · 1999 · 148 citations · Full text

Medicine, Oncology, Surgery +17

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy?

R.T.D. Oliver, Polly Edmonds, J. Ong et al. · International Journal of Radiation Oncology*Biology*Physics · 1994 · 133 citations

Medicine, Oncology, Chemotherapy +9

long-term follow-up of anglian germ cell cancer group surveillance versus patients with stage 1 nonseminoma treated with adjuvant chemotherapy

R.T.D. Oliver, J. Ong, Jonathan Shamash et al. · Urology · 2004 · 108 citations

Medicine, Oncology, Chemotherapy +12